Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 6;324(13):1279-1281.
doi: 10.1001/jama.2020.16656.

COVID-19 and the Path to Immunity

David S Stephens  1 , M Juliana McElrath  2
Affiliations

COVID-19 and the Path to Immunity

David S Stephens et al. JAMA. .
No abstract available

PubMed Disclaimer

Figures

Figure.
Figure.. Adaptive Immunity to Coronavirus Disease 2019
Generalized model of T-cell and B-cell (plasmablast, antibody) responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection projected over 1 year following infection. Neutralizing antibodies, memory 4 B cells, and CD4+ and CD8+ memory T cells to SARS-CoV-2, which are generated by infection, vaccination, or after reexposure, are key to the path to immunity. The dotted lines represent peak B-cell, T-cell, and antibody responses following infection.
See this image and copyright information in PMC

References

    1. Grifoni A, Weiskopf D, Ramirez SI, et al. Targets of T cell responses to SARS-CoV-2 coronavirus in Humans with COVID-19 disease and unexposed individuals. Cell. 2020;181(7):1489–1501.e15. doi: 10.1016/j.cell.2020.05.015 - DOI - PMC - PubMed
    1. Suthar MS, Zimmerman MG, Kauffman RC, et al. Rapid generation of neutralizing antibody responses in COVID-19 patients. Cell Rep Med. 2020;1(3):100040. Published online June 23, 2020. doi: 10.1016/j.xcrm.2020.100040 - DOI - PMC - PubMed
    1. Robbiani DF, Gaebler C, Muecksch F, et al. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature. Published online June 18, 2020. doi: 10.1038/s41586-020-2456-9 - DOI - PMC - PubMed
    1. Mathew D, Giles JR, Baxter AE, et al. ; UPenn COVID Processing Unit. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science. Published online July 15, 2020. - PMC - PubMed
    1. Le Bert N, Tan AT, Kunasegaran K, et al. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature. Published online July 15, 2020. doi: 10.1038/s41586-020-2550-z - DOI - PubMed